Welcome to Entry Card of Lysosomal Enzymes


Details of RareLED ID Assay_1021
Primary information
GENEFUCA1
NUMBER OF ASSAY73
ASSAY IDs241392 241366 241029 238243 240927 240839 36827 36819 397849 400770 289004 261196 36836 36818 36960 36835 36834 36833 36812 218953 218952 218951 218950 218949 218948 218947 218946 36837 36828 338560 36964 36952 36820 36840 263091 36813 36959 36958 36842 36830 36829 36817 36816 36811 779304 779303 779302 760663 760618 638946 613057 491858 488410 453109 264563 264562 36694 218941 218940 218939 218830 218795 218794 218793 218792 36996 219478 219477 36998 36839 36838 36832 36831
Assay Name1. Inhibitory concentration against alpha-L-fucosidase of bovine epididymis,2. Inhibitory concentration against bovine alpha-L-fucosidase,3. Inhibitory concentration against human alpha-L-fucosidase,4. Ki value against bovine alpha-L-fucosidase,5. Inhibitory concentration against human alpha-fucosidase,6. Inhibitory concentration against human alpha-fucosidase,7. Binding affinity against alpha-L-fucosidase in bovine kidney was determined,8. Inhibition of bovine kidney alpha-L-fucosidase,9. Inhibition of bovine epididymis alpha-L-fucosidase assessed as p-nitrophenol release after 30 mins by spectrophotometry,10. Inhibition of bovine epididymis alpha-L-fucosidase at 1000 uM,11. Inhibition of human placenta alpha-L-fucosidase,12. Inhibition of bovine alpha-L-fucosidase,13. Inhibitory activity measured against alpha-L-fucosidase of bovine epididymis by colorimetric assay using the D-glucose oxidase-peroxidase method,14. Inhibitory activity measured against alpha-L-fucosidase of bovine epididymis by colorimetric assay using the D-glucose oxidase-peroxidase method,15. Inhibitory activity against alpha-L-Fucosidase of human placenta expressed as Ki,16. In vitro inhibition of alpha-L-fucosidase isolated from bovine kidney.,17. Inhibitory activity against alpha-L-fucosidase of bovine epididymis expressed as Ki,18. Inhibitory activity against alpha-L-Fucosidase of bovine epididymis expressed as Ki,19. Inhibitory activity against alpha-L-fucosidase of bacillus species (K40T) expressed as Ki,20. Inhibitory activity against alpha-L-fucosidase in human placenta at PH of 6.5; Mixed Inhibition type,21. Inhibitory activity against alpha-L-fucosidase in bovine kidney; Competitive Inhibition type,22. Inhibitory activity against alpha-L-fucosidase in bovine kidney at PH of 6.5; Mixed Inhibition type,23. Inhibitory activity against alpha-L-fucosidase in bovine epididymis; Competitive Inhibition type,24. Inhibitory activity against alpha-L-fucosidase in bovine epididymis at PH of 6.5; Competitive Inhibition type,25. Compound was tested for inhibitory activity against alpha-L-fucosidase from bovine epididymis,26. Compound was tested for inhibitory activity (mixed) against alpha-L-fucosidase from bovine kidney,27. Compound was tested for inhibitory activity (competitive) against alpha-L-fucosidase from bovine kidney,28. Tested for inhibitory activity against alpha-L-fucosidase from bovine epididymus (sigma),29. Compound was tested for the inhibitory activity against alpha-L-fucosidase from bovine epididymis,30. Inhibition of bovine epididymis alpha-L-fucosidase assessed as p-nitrophenol release by spectrophotometrically,31. Inhibitory activity measured against alpha-L-fucosidase of rat epididymis by colorimetric assay using the D-glucose oxidase-peroxidase method,32. Inhibitory concentration against alpha-L-Fucosidase of human placenta,33. Inhibitory concentration against alpha-L-Fucosidase of bovine epididymis,34. The Michaelis-Menten constant against alpha-L-fucosidase from bovine epididymus (sigma) was determined,35. Inhibition of human liver alpha-L-fucosidase,36. Concentration that causes 50% inhibition of mammalian alpha-L-fucosidase was determined in bovine epididymis,37. Inhibition constant (Competitive)of the compound against alpha-L-Fucosidase from Human placenta,38. Inhibition constant (Competitive) against alpha-l-Fucosidase from Human placenta,39. Inhibitor concentration against alpha-L-Fucosidase from Human placenta,40. Inhibition constant (Competitive) against alpha-l-Fucosidase from Bovine epididymis,41. Inhibition constant (Competitive) against alpha-L-Fucosidase from Bovine epididymis,42. Inhibitor concentration against alpha-L-Fucosidase from Bovine epididymis was tested,43. Inhibitor concentration against alpha-L-Fucosidase from Bovine epididymis,44. The compound was tested for the inhibitory activity against alpha-L-Fucosidase in bovine kidney,45. Inhibition of bovine kidney alpha-L-fucosidase assessed as inhibition of release of p-nitrophenol by spectrophotometry,46. Inhibition of rat epididymis alpha-L-fucosidase assessed as inhibition of release of p-nitrophenol by spectrophotometry,47. Inhibition of human lysosome alpha-L-fucosidase using 4-methylumbelliferyl-alpha-L-fucopyranoside by spectrophotometry,48. Inhibition of bovine kidney alpha-L-fucosidase,49. Inhibition of bovine alpha-L-fucosidase,50. Inhibition of bovine kidney alpha-L-fucosidase,51. Inhibition of bovine epididymis alpha-L-fucosidase assessed as production of p-nitrophenol by spectrophotometry,52. Inhibition of bovine kidney alpha L-fucosidase,53. Inhibition of bovine epididymis alpha-L-fucosidase assessed as p-nitrophenol release at pH 5.5 by spectrometric analysis,54. Inhibition of bovine kidney alpha-L-fucosidase by para-nitrophenolate release assay,55. Inhibition of human placenta alpha fucosidase at pH 6.8,56. Inhibition of bovine kidney alpha fucosidase at pH 6.8,57. Inhibitory activity against alpha-Fucosidase in bovine kidney,58. Compound was tested for inhibitory activity against alpha-Fucosidase obtained from Bovine kidney,59. Compound was tested for inhibitory activity against alpha-Fucosidase obtained from Bovine epididymis,60. Compound was tested for inhibitory activity against alpha-Fucosidase obtained from Bovine kidney,61. Compound was tested for inhibitory activity against alpha-Fucosidase obtained from Bovine epididymis,62. Compound was tested for inhibitory activity against alpha-1,2-Fucosidase obtained from Arthrobacter oxidans F1,63. Compound was tested for inhibitory activity against alpha-1,2-Fucosidase obtained from Arthrobacter oxidans F1,64. Compound was tested for inhibitory activity against alpha-1,2-Fucosidase obtained from Arthrobacter oxidans F1,65. Compound was tested for inhibitory activity against alpha-1,2-Fucosidase obtained from Arthrobacter oxidans,66. Inhibitory activity against alpha-fucosidase from bovine epididymis,67. Compound was evaluated for inhibition of alpha-fucosidase from bovine kidney(sigma F 5884) at pH 6.8,68. Compound was evaluated for inhibition of alpha-fucosidase from bovine kidney(sigma F 5884).,69. Compound was tested for inhibition of alpha-fucosidase from bovine kidney.,70. Slope inhibition constant against Alpha-Fucosidase; Uncompetitive inhibition,71. Intecept inhibition constant against Alpha-Fucosidase; Noncompetitive inhibition,72. Inhibition constant against Alpha-Fucosidase; Uncompetitive inhibition,73. Inhibition constant against Alpha-Fucosidase
ACTIVITYSubstance BioActivity: 1 Active, 2 Tested Substance BioActivity: 1 Active, 1 Activity <= 1 µM, 1 Tested Substance BioActivity: 1 Active, 1 Tested Substance BioActivity: 6 Active, 4 Activity <= 1 µM, 6 Tested Substance BioActivity: 2 Tested Substance BioActivity: 1 Active, 2 Tested Substance BioActivity: 10 Active, 9 Activity <= 1 µM, 10 Tested Substance BioActivity: 11 Active, 7 Activity <= 1 µM, 13 Tested Substance BioActivity: 2 Active, 4 Tested Substance BioActivity: 1 Tested Substance BioActivity: 1 Active, 2 Tested Substance BioActivity: 5 Active, 2 Activity <= 1 nM, 3 Activity <= 1 µM, 6 Tested Substance BioActivity: 3 Active, 2 Activity <= 1 µM, 3 Tested Substance BioActivity: 3 Active, 3 Tested Substance BioActivity: 6 Active, 6 Tested Substance BioActivity: 18 Active, 7 Activity <= 1 µM, 18 Tested Substance BioActivity: 4 Active, 2 Activity <= 1 µM, 5 Tested Substance BioActivity: 6 Active, 6 Tested Substance BioActivity: 1 Active, 1 Activity <= 1 µM, 1 Tested Substan